Coffee and cirrhosis: Active ingredients? [2]

Archives of Internal Medicine

Volumn 166, Issue 21, 2006, Pages 2404-2405

  Vinson, Joe A ^a  

^a UNIVERSITY OF SCRANTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; GALACTOSAMINE;

COFFEE; DIET; HUMAN; LETTER; LIVER CIRRHOSIS; MEDICAL RESEARCH; PRIORITY JOURNAL; TEA;

EID: 33751522308     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.166.21.2404-b     Document Type: Letter

References (6)

1. Klatsky AL, Morton C, Udaltsova N, Friedman GD. Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med. 2006;166:1190-1195.
2. Ruhl CE, Everhart JE. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology. 2005;129:1928-1936.
3. Clifford MN. Chlorogenic acids and other cinnametes-nature occurrence, dietary burden, absorption and metabolism. J Sci Food Agric. 2000;80:1033-1043.
4. Vinson JA, Proch J, Bose P, et al. Chocolate is a powerful ex vivo and in vivo antioxidant, an antiatherosclerotic agent in an animal model, and a significant contributor to antioxidants in the European and American diets [published online ahead of print September 19, 2006]. J Agric Food Chem. 2006. Accessed September 19, 2006. doi:10.1021/jf062175j.
5. Janbaz KH, Saeed SA, Gilani AH. Studies on the protective effects of caffeic acid and quercetin on chemical-induced hepatotoxicity in rodents. Phytomedicine. 2004;11:424-430.
6. Feng R, Lu Y, Bowmann LL, Qian Y, Castranova V, Ding M. Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem. 2005;280:27888-27895.